Korean J Intern Med.
2022 Jan;37(1):243-244. 10.3904/kjim.2021.143.
Clinical course of severe esophagitis following bevacizumab therapy
- Affiliations
-
- 1Department of Internal Medicine, Dankook University Hospital, Dankook University College of Medicine, Cheonan, Korea
- KMID: 2524260
- DOI: http://doi.org/10.3904/kjim.2021.143
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Atezolizumab and bevacizumab for hepatocellular carcinoma: How to approach salvage therapy for non-responders?: Editorial on “Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study”
- Clinical Review of Eosinophilic Esophagitis
- Hereditary hemorrhagic telangiectasia treated with low dose intravenous bevacizumab
- Recurrent Conjunctival Granuloma Treated with Subconjunctival Bevacizumab
- A Case of Acneiform Eruption Induced by Bevacizumab
